|
Volumn 62, Issue 4, 2005, Pages
|
New drug and biological product approvals, 2004
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACAMPROSATE;
APOMORPHINE;
AZACITIDINE;
BEVACIZUMAB;
BIOLOGICAL PRODUCT;
CISPLATIN;
CLOFARABINE;
ESZOPICLONE;
ILOPROST;
KETOLIDE;
NATALIZUMAB;
NEW DRUG;
OMEGA CONOTOXIN MVIIA;
PALIFERMIN;
PEMETREXED;
TELITHROMYCIN;
TINIDAZOLE;
TIOTROPIUM BROMIDE;
ACUTE LYMPHOBLASTIC LEUKEMIA;
ALCOHOLISM;
BONE MARROW TRANSPLANTATION;
BRONCHOSPASM;
CANCER CHEMOTHERAPY;
CHRONIC BRONCHITIS;
CHRONIC OBSTRUCTIVE LUNG DISEASE;
CHRONIC PAIN;
COLON CANCER;
COMMUNITY ACQUIRED PNEUMONIA;
DEGENERATIVE DISEASE;
DRUG APPROVAL;
DRUG MARKETING;
ENTAMOEBA HISTOLYTICA;
FOOD AND DRUG ADMINISTRATION;
GIARDIA DUODENALIS;
HUMAN;
INSOMNIA;
LUNG NON SMALL CELL CANCER;
MUCOSA INFLAMMATION;
MULTIPLE SCLEROSIS;
MYELODYSPLASTIC SYNDROME;
NOTE;
PARKINSON DISEASE;
PHYSICAL ACTIVITY;
PLEURA MESOTHELIOMA;
PRIORITY JOURNAL;
PULMONARY HYPERTENSION;
RECTUM CANCER;
SINUSITIS;
STREPTOCOCCUS PNEUMONIAE;
TRICHOMONAS VAGINALIS;
TRICHOMONIASIS;
|
EID: 15444371175
PISSN: 10792082
EISSN: None
Source Type: Journal
DOI: 10.1093/ajhp/62.4.348 Document Type: Note |
Times cited : (3)
|
References (0)
|